title: Type 2 diabetes and cardiovascular disease: A metabolic overview of recent clinical trials.
authors: The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; The Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
authors: Yochai
authors: Y
authors: Birnbaum
authors: The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
authors: Yumei
authors: Y
authors: Ye
authors: Endocrinology and Diabetes Division, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: bajaj@bcm.edu.
authors: Mandeep
authors: M
authors: Bajaj
mesh_terms: D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism*; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D005260:Female; D006801:Humans; D000069450:Liraglutide / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism; D008875:Middle Aged; D010455:Peptides / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D000067758:Glucagon-Like Peptide-2 Receptor
chemical_list: D000069450:Liraglutide; D010455:Peptides; C479460:lixisenatide; D000067758:Glucagon-Like Peptide-2 Receptor